Liposome-based drug delivery using secretory phospholipase A2 as a tumor specific release mechanism: preclinical evaluation of efficacy, pharmaco-kinetics and individual patient expression profiles.
Proceedings article published in 2007 by
J. E. Larsen,
J. R. Henriksen,
M. Bæksted,
T. L. Andresen,
Frederik Dagnæs-Hansen 
,
G. K. Jacobsen,
K. Jørgensen
,
G. K. Jacobsen,
K. Jørgensen
